Selectis Health Reports Revenue Growth and Net Income Turnaround in Q3 2025

Selectis Health, Inc. reported its financial results for the third quarter and the first nine months of 2025, revealing a notable improvement in its financial performance compared to the same period in 2024. For the three months ended September 30, 2025, the company generated total revenue of $10.84 million, an increase of 8% from $10.02 million in the prior year. Healthcare revenue specifically rose to $10.84 million from $10.02 million, attributed to higher Medicaid reimbursement rates at its facilities in Georgia and Oklahoma. However, the company recorded a net income of $752,365 for the quarter, a significant turnaround from a net loss of $1.61 million in the same quarter of 2024.

For the nine months ending September 30, 2025, Selectis Health reported total revenue of $31.77 million, up 10% from $29.09 million in the previous year. The increase in healthcare revenue was again a key driver, rising to $31.77 million from $28.77 million. Despite this growth, the company faced a net loss of $211,631 for the nine-month period, an improvement from a loss of $1.85 million in the same timeframe last year. The reduction in losses was attributed to lower provisions for credit losses and decreased interest expenses, which fell to $974,358 from $1.69 million.

Operationally, Selectis Health has maintained a consistent employee headcount of 3,067,059 shares of common stock outstanding. The company’s total assets as of September 30, 2025, were reported at $33.26 million, slightly down from $33.45 million at the end of 2024. Total liabilities increased marginally to $38.92 million from $38.86 million, with current liabilities rising to $20.30 million. The company’s accumulated deficit also widened to $20.43 million from $20.19 million, reflecting ongoing challenges in achieving profitability.

In terms of strategic developments, Selectis Health has been focusing on enhancing its liquidity and operational efficiency. The company has plans to increase occupancy rates in its facilities and control operating expenses. Additionally, it is exploring options for raising capital through debt or equity securities. The company’s management has expressed concerns regarding its ability to continue as a going concern, given its working capital deficiency of approximately $16.3 million as of September 30, 2025. The outlook remains cautious, with management emphasizing the need for successful execution of its strategies to improve liquidity and profitability in the coming months.

Overall, while Selectis Health has shown signs of recovery in its financial performance, the company continues to navigate significant operational and financial challenges as it seeks to stabilize and grow its business in the competitive healthcare sector.